Rise at Smith & Nephew from woundcare


The artificial knee and hip markets are sagging in Europe, but medical instruments and joints-maker Smith & Nephew managed a 10 per cent rise in trading profits to $207m (£128m) in the third quarter.

The company faces "significant challenges" in Europe, which accounts for 30 per cent of revenues, but said its woundcare business was growing at twice the rate of the rest of the market and held its outlook unchanged.